These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 38945003

  • 1. Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study.
    Arrieta O, Caballé-Pérez E, Hernández-Pedro N, Romero-Nuñez E, Lucio-Lozada J, Castillo-Ruiz C, Acevedo-Castillo K, María Álvarez-Gómez R, Molina-Garay C, Jiménez-Olivares M, Carrillo-Sánchez K, Cristina Mendoza-Caamal E, Cardona AF, Remon J, Alaez-Verson C.
    Lung Cancer; 2024 Aug; 194():107864. PubMed ID: 38945003
    [Abstract] [Full Text] [Related]

  • 2. Rate of Pathogenic Germline Variants in Patients With Lung Cancer.
    Sorscher S, LoPiccolo J, Heald B, Chen E, Bristow SL, Michalski ST, Nielsen SM, Lacoste A, Keyder E, Lee H, Nussbaum RL, Martins R, Esplin ED.
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [Abstract] [Full Text] [Related]

  • 3. Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400.
    Woodward ER, Lalloo F, Forde C, Pugh S, Burghel GJ, Schlecht H, Harkness EF, Howell A, Howell SJ, Gandhi A, Evans DG.
    J Med Genet; 2024 Mar 21; 61(4):385-391. PubMed ID: 38123987
    [Abstract] [Full Text] [Related]

  • 4. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
    Brand R, Borazanci E, Speare V, Dudley B, Karloski E, Peters MLB, Stobie L, Bahary N, Zeh H, Zureikat A, Hogg M, Lee K, Tsung A, Rhee J, Ohr J, Sun W, Lee J, Moser AJ, DeLeonardis K, Krejdovsky J, Dalton E, LaDuca H, Dolinsky J, Colvin A, Lim C, Black MH, Tung N.
    Cancer; 2018 Sep 01; 124(17):3520-3527. PubMed ID: 30067863
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.
    Shore N, Gazi M, Pieczonka C, Heron S, Modh R, Cahn D, Belkoff LH, Berger A, Mazzarella B, Veys J, Idom C, Morris D, Jayram G, Engelman A, Bukkapatnam R, Dato P, Bevan-Thomas R, Cornell R, Wise DR, Hardwick MK, Hernandez RD, Rojahn S, Layman P, Hatchell KE, Heald B, Nussbaum RL, Nielsen SM, Esplin ED.
    Eur Urol Oncol; 2023 Oct 01; 6(5):477-483. PubMed ID: 37574391
    [Abstract] [Full Text] [Related]

  • 6. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
    Heald B, Mokhtary S, Nielsen SM, Rojahn S, Yang S, Michalski ST, Esplin ED.
    Gynecol Oncol; 2022 Aug 01; 166(2):344-350. PubMed ID: 35691755
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
    Kumari N, Singh RK, Mishra SK, L R, Mohindra S, Krishnani N.
    Pathol Res Pract; 2021 Jan 01; 217():153309. PubMed ID: 33341547
    [Abstract] [Full Text] [Related]

  • 8. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
    Chen X, Meyer MA, Kemppainen JL, Horibe M, Chandra S, Majumder S, Petersen GM, Rabe KG.
    JAMA Oncol; 2023 Jul 01; 9(7):955-961. PubMed ID: 37200008
    [Abstract] [Full Text] [Related]

  • 9. Extended gene panel testing in lobular breast cancer.
    van Veen EM, Evans DG, Harkness EF, Byers HJ, Ellingford JM, Woodward ER, Bowers NL, Wallace AJ, Howell SJ, Howell A, Lalloo F, Newman WG, Smith MJ.
    Fam Cancer; 2022 Apr 01; 21(2):129-136. PubMed ID: 33763779
    [Abstract] [Full Text] [Related]

  • 10. Germline mutations and age at onset of lung adenocarcinoma.
    Reckamp KL, Behrendt CE, Slavin TP, Gray SW, Castillo DK, Koczywas M, Cristea MC, Babski KM, Stearns D, Marcum CA, Rodriguez YP, Hass AJ, Vecchio MM, Mora P, Cervantes AE, Sand SR, Mejia RM, Tsou TC, Salgia R, Weitzel JN.
    Cancer; 2021 Aug 01; 127(15):2801-2806. PubMed ID: 33858029
    [Abstract] [Full Text] [Related]

  • 11. High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands.
    Yoshida R, Kaneyasu T, Ueki A, Yamauchi H, Ohsumi S, Ohno S, Aoki D, Baba S, Kawano J, Matsumoto N, Nagasaki M, Ueno T, Inari H, Kobayashi Y, Takei J, Gotoh O, Nishi M, Okamura M, Kaneko K, Okawa M, Suzuki M, Amino S, Inuzuka M, Noda T, Mori S, Nakamura S.
    Breast Cancer; 2024 Nov 01; 31(6):1028-1036. PubMed ID: 39003386
    [Abstract] [Full Text] [Related]

  • 12. Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study.
    Choudry MM, Durant AM, Edmonds VS, Warren CJ, Kunze KL, Golafshar MA, Nielsen SM, Esplin ED, Andrews JR, Samadder NJ, Tyson MD.
    J Urol; 2024 Oct 01; 212(4):590-599. PubMed ID: 38860938
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
    Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze KL, Golafshar M, Uson PLS, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez EA, Lizaola-Mayo B, Lehrer M, Thorpe CS, Yu NY, Esplin ED, Nussbaum RL, Sharp RR, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce AH, Bekaii-Saab TS, Sekulic A, Stewart AK.
    JAMA Oncol; 2021 Feb 01; 7(2):230-237. PubMed ID: 33126242
    [Abstract] [Full Text] [Related]

  • 14. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B, McFarland R, Pesaran T, Huether R, LaDuca H, Chao EC, Goldgar DE, Dolinsky JS.
    JAMA Oncol; 2017 Sep 01; 3(9):1190-1196. PubMed ID: 28418444
    [Abstract] [Full Text] [Related]

  • 15. Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study.
    Hutchcraft ML, Zhang S, Lin N, Pickarski JC, Belcher EA, Wei S, Bocklage T, Miller RW, Villano JL, Cavnar MJ, Kim J, Arnold SM, Ueland FR, Kolesar JM.
    JCO Precis Oncol; 2024 Jan 01; 8():e2300266. PubMed ID: 38295319
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.
    Abdel-Razeq H, Al-Azzam K, Elemian S, Abu-Fares H, Abu Sheikha A, Bani Hani H, Bater R, Sharaf B, Heald B, Esplin ED, Nielsen SM, Alkyam M, Abujamous L, Al-Attary A.
    Mol Genet Genomic Med; 2023 Apr 01; 11(4):e2125. PubMed ID: 36537080
    [Abstract] [Full Text] [Related]

  • 17. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA, Baig MK, Milewski B, Keywan C, Guarino M, Petrelli N.
    Ann Surg Oncol; 2016 May 01; 23(5):1729-35. PubMed ID: 26727920
    [Abstract] [Full Text] [Related]

  • 18. Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
    Wang X, Waldman L, Silberman Y, Wang M, Tackey C, Hanna L, Vesprini D, Emmenegger U, Eisen A, Smoragiewicz M.
    Clin Genitourin Cancer; 2024 Jun 01; 22(3):102052. PubMed ID: 38461085
    [Abstract] [Full Text] [Related]

  • 19. Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas.
    De Sousa SMC, McCormack A, Orsmond A, Shen A, Yates CJ, Clifton-Bligh R, Santoreneos S, King J, Feng J, Toubia J, Torpy DJ, Scott HS.
    J Clin Endocrinol Metab; 2024 Oct 15; 109(11):2720-2728. PubMed ID: 38651569
    [Abstract] [Full Text] [Related]

  • 20. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG, Johnson AM, Hanson KL, Dayno ME, Kapron AL, Stoffel EM, Cooney KA.
    Cancer; 2017 Oct 15; 123(20):3925-3932. PubMed ID: 28657667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.